HP N = 24 | HTG N = 31 | p | |
---|---|---|---|
Total cholesterol | 6.96 ± 3.72 | 6.56 ± 1.68 | NS |
TG | 3.53 (2.07–8.75) | 4.87 (2.70–8.41) | NS |
VLDL-Chol | 0.83 ± 0.44 | 0.91 ± 0.47 | NS |
HDL-Chol | 0.91 ± 0.49 | 0.88 ± 0.39 | NS |
LDL-Chol | 2.95 ± 1.47 | 3.28 ± 1.40 | NS |
VLDL-TG | 1.39 (1.06–1.97) | 1.41 (1.10–2.32) | NS |
HDL-TG | 0.34 (0.23–0.46) | 0.31 (0.25–0.44) | NS |
LDL-TG | 0.58 (0.42–0.64) | 0.53 (0.41–0.69) | NS |
Chylomicron Chol | 4.29 ± 5.43 | 2.17 ± 1.53 | NS |
Chylomicron TG | 5.30 (2.73–11.52) | 3.63 (2.30–6.40) | NS |
Apo A-I | 1.04 ± 0.36 | 1.10 ± 0.30 | NS |
Apo B-100 | 0.91 ± 0.32 | 0.96 ± 0.27 | NS |
Apo CII | 0.11 ± 0.05 | 0.13 ± 0.07 | NS |
Apo CIII | 0.17 ± 0.07 | 0.20 ± 0.09 | NS |
Apo E | 0.09 ± 0.04 | 0.11 ± 0.06 | NS |
ApoCIII/ApoCII | 2.8 ± 4 | 1.7 ± 0.7 | NS |
Apo E Genotype | NS | ||
E3/E2 | 1 (4) | 5 (16) | |
E3/E3 | 19 (79) | 22 (73) | |
E3/E4 | 2 (8) | 3 (10) | |
E2/E4 | 2 (8) | 0 | |
Apo A-V, allele S19W | 8 (32) | 7 (23) | NS |
LPLactivity (mU/ml) | 69 ± 44 | 92 ± 44 | 0.057 |
HL-activity (mU/ml) | 164 ± 94 | 194 ± 84 | NS |
Posth-LPLmass (ng/ml) | 312 ± 192 | 411 ± 195 | 0.06 |
Preh-LPLmass (ng/ml) | 18 ± 11 | 22 ± 14 | NS |